FY26 B1 foundation care pharm chemo FEB 26
Ended Awarded Last action
- Contract number
- 15B40626F00000093
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI ENNFDLWFC6L1
- Awarding agency
-
Federal Correctional Complex Florence
Correctional Facilities, Department of Justice
- Obligated
- $14,386
Award facts
- Contract value 100% obligated
- $14,385.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Sand Lake, FL 32819, USA
Award details come from SAM.gov/FPDS.
About this award
The Federal Correctional Complex Florence awarded a firm fixed-price delivery order valued at $14,385.75 to Takeda Pharmaceuticals America, Inc. on February 1, 2026, for foundation care pharmaceutical chemotherapy products with an ultimate completion date of February 28, 2026. This delivery order carries no small business set-aside designation and represents work to be performed in Orlando, Florida. Takeda Pharmaceuticals America, a Cambridge, Massachusetts-based subsidiary of Japan's Takeda Pharmaceutical Company Limited, is a major federal supplier of specialized oncology medications, particularly ICLUSIG (ponatinib), a targeted cancer therapy for chronic myeloid leukemia and acute lymphoblastic leukemia treatment.
This delivery order is a child contract under Takeda's parent General Services Administration Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), a multiple-award schedule valued at $2.89 billion extending through September 28, 2030. The GSA schedule framework enables federal agencies and correctional healthcare systems to efficiently procure specialized pharmaceutical products while maintaining price certainty. Takeda's federal contracting presence extends primarily through the Department of Veterans Affairs, where the company supplies oncology medications across multiple Veterans Integrated Service Networks, though this award demonstrates the company's expanding role as a critical pharmaceutical supplier to other federal healthcare institutions beyond the VA system.
Quick answers
Who was awarded contract 15B40626F00000093?
15B40626F00000093 was awarded to Takeda Pharmaceuticals America, Inc. by Federal Correctional Complex Florence (Correctional Facilities) on February 1, 2026.
How much is contract 15B40626F00000093 worth?
The government has obligated $14,386 on 15B40626F00000093.
Is contract 15B40626F00000093 an order under another contract?
Yes. 15B40626F00000093 is a delivery order under 36F79718D0586, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 15B40626F00000093 competed?
The extent of competition for 15B40626F00000093 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award